With its $ 63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a pall over the near-term future. But AbbVie figures its homegrown prospects will keep driving growth—and a couple of surprises from Allergan could make the forecast even rosier. After six… Read More »
THURSDAY, Oct. 22, 2020 — If Obamacare, or the Affordable Care Act (ACA), is repealed, pediatric cancer patients could lose critical insurance coverage, a new study warns. Kids with cancer often require intensive treatment and long-term follow-up to beat the disease. The ACA allows them to stay on their parents’ insurance coverage to age 26… Read More »
By Serena Gordon HealthDay Reporter WEDNESDAY, Oct. 21, 2020 (HealthDay News) — Low levels of thyroid hormone during pregnancy may contribute to the development of attention deficit hyperactivity disorder in the child, new research suggests. The study found that children born to mothers with low thyroid hormone levels during the first trimester of pregnancy had… Read More »
By MIKE MAGEE Cautionary tales are timeless. Take for example Aesop’s Fables, from 620 BC, which included the advisory, “Be careful what you wish for lest it come true.” Trump and the Republicans who oppose the ACA take heed. You may be inadvertently taking the entire collusive Medical-Industrial Complex down a rabbit hole. In the… Read More »
The Covid-19 pandemic has challenged all facets of human endeavours, and seven months later the economic effects are particularly being felt How the world can leverage the positive and negative effects of COVID-19 to build a new, more resilient and low-carbon economy has been analysed by a group of academics led by WMG, University of… Read More »